WELL Health Technologies Corp
TSX:WELL
Intrinsic Value
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. [ Read More ]
The intrinsic value of one
WELL
stock under the Base Case scenario is
6.32
CAD.
Compared to the current market price of 3.59 CAD,
WELL Health Technologies Corp
is
Undervalued by 43%.
WELL Health Technologies Corp's market capitalization is 866.7m CAD.
WELL stock price is 3.59 CAD.
WELL stock price (3.59 CAD) is 43% less than its Intrinsic Value (6.32 CAD).
WELL has upside potential of 111% compared to the average analyst price target.
Open Wall St Estimates
WELL's short-term assets (176m CAD) exceed its short-term liabilties (153m CAD).
WELL's Revenue is forecast to fall at a rate of 3% per year over the next 3 years.
WELL's ROE (Return on Equity) has increased in the last 3 years from -7% to 0%.
WELL's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 2%.
WELL has positive Free Cash Flow for the last twelve months.
WELL's ROE (Return on Equity) for the past 12 months is very low and is equal to 0%.
WELL's Revenue has grown by an exceptional 36% over the past 12 months.
WELL's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -9% to 2%.
WELL has positive Operating Income for the last twelve months.
WELL has negative three-year average ROIC (Return on Invested Capital): 0%. The company is not efficient at using invested capital to generate operating income.
WELL has positive Net Income for the last twelve months.
WELL's long-term assets (1B CAD) exceed its long-term liabilties (642m CAD).
WELL has positive Gross Profit for the last twelve months.
WELL has negative three-year average ROE (Return on Equity): -5%. The company is not efficient at transforming stockholders' equity into net income.
WELL's D/E (Debt to Equity) is very low and is equal to 0.48.
WELL's Altman Z-Score is very low and is equal to 1.42.
WELL's Revenue has been growing by an exceptional 149% per year for the last 3 years.
WELL has positive Net Debt. This means that the company has more debt (365m CAD) than cash and short-term investments (43m CAD).
WELL generates enough operating income (35m CAD) to cover interest payments on its debt (23m CAD).
Valuation Backtest
WELL Health Technologies Corp
Run backtest to discover the historical profit from buying and selling
WELL
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
WELL Health Technologies Corp
Balance Sheet Decomposition
WELL Health Technologies Corp
| Current Assets | 176.4m |
| Cash & Short-Term Investments | 43.4m |
| Receivables | 96.1m |
| Other Current Assets | 36.9m |
| Non-Current Assets | 1.2B |
| Long-Term Investments | 60.9m |
| PP&E | 102.5m |
| Intangibles | 1.1B |
| Other Non-Current Assets | 6.2m |
| Current Liabilities | 153m |
| Accounts Payable | 47.9m |
| Accrued Liabilities | 12.5m |
| Other Current Liabilities | 92.6m |
| Non-Current Liabilities | 488.7m |
| Long-Term Debt | 365.3m |
| Other Non-Current Liabilities | 123.4m |
Earnings Waterfall
WELL Health Technologies Corp
|
Revenue
|
776.1m
CAD
|
|
Cost of Revenue
|
-403.8m
CAD
|
|
Gross Profit
|
372.3m
CAD
|
|
Operating Expenses
|
-337.7m
CAD
|
|
Operating Income
|
34.5m
CAD
|
|
Other Expenses
|
-34.4m
CAD
|
|
Net Income
|
82k
CAD
|
Free Cash Flow Analysis
WELL Health Technologies Corp
WELL Profitability Score
Profitability Due Diligence
WELL Health Technologies Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
WELL Health Technologies Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
WELL Solvency Score
Solvency Due Diligence
WELL Health Technologies Corp's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Score
WELL Health Technologies Corp's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WELL Price Targets Summary
WELL Health Technologies Corp
According to Wall Street analysts, the average 1-year price target for
WELL
is 7.57 CAD
with a low forecast of 4.8 CAD and a high forecast of 11.55 CAD.
Shareholder Return
WELL Price
WELL Health Technologies Corp
| Average Annual Return | 117.61% |
| Standard Deviation of Annual Returns | 212.59% |
| Max Drawdown | -72% |
| Market Capitalization | 866.7m CAD |
| Shares Outstanding | 241 427 825 |
| Percentage of Shares Shorted | 1.84% |
Company Profile
WELL Health Technologies Corp
Country
Industry
Market Cap
Dividend Yield
Description
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. The company is headquartered in Vancouver, British Columbia and currently employs 1,507 full-time employees. The company went IPO on 2012-12-17. The firm is engaged in operating primary healthcare facilities in both Canada and United States, as well as a digital electronic medical records (EMR) business. The firm provides software as a service (SaaS) EMR services to doctors across Canada. The company operates as a national telehealth service and is a provider of digital health, billing and cybersecurity related technology solutions. The firm owns and operates medical clinics and provides digital EMR software and services to medical clinics across Canada. Its clinics offers a range of services such as walk in appointments, family medicine, sleep apnea facilities, Botox treatments, and women’s clinics. The firm's wholly owned subsidiary, CRH Medical, is engaged in providing anesthesia services. The firm is also engaged in the business of providing secure clinic management, telehealth and practice management software related services.
Contact
IPO
Employees
Officers
The intrinsic value of one
WELL
stock under the Base Case scenario is
6.32
CAD.
Compared to the current market price of 3.59 CAD,
WELL Health Technologies Corp
is
Undervalued by 43%.
You don't have any saved screeners yet
